Creative Planning Has $650,000 Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

Creative Planning boosted its position in Bath & Body Works, Inc. (NYSE:BBWI) by 8.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,648 shares of the company’s stock after buying an additional 1,254 shares during the quarter. Creative Planning’s holdings in Bath & Body Works were worth $650,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Anomaly Capital Management LP acquired a new stake in shares of Bath & Body Works in the second quarter worth $113,995,000. Lone Pine Capital LLC grew its position in Bath & Body Works by 15.8% during the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock worth $441,871,000 after buying an additional 1,547,399 shares in the last quarter. Vanguard Group Inc. raised its holdings in Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock valued at $1,370,458,000 after acquiring an additional 1,102,124 shares in the last quarter. Interval Partners LP grew its holdings in shares of Bath & Body Works by 230.0% during the 2nd quarter. Interval Partners LP now owns 1,280,593 shares of the company’s stock worth $50,007,000 after purchasing an additional 892,488 shares in the last quarter. Finally, Ceredex Value Advisors LLC bought a new stake in shares of Bath & Body Works during the second quarter valued at approximately $25,867,000. Institutional investors own 95.14% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Evercore ISI lowered their price target on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a report on Wednesday, August 28th. Piper Sandler lowered their target price on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a research note on Thursday, July 11th. Citigroup dropped their price objective on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research report on Tuesday, August 20th. Robert W. Baird lowered their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Finally, Barclays lowered their price objective on Bath & Body Works from $32.00 to $31.00 and set an “equal weight” rating for the company in a research report on Thursday, August 29th. Eight analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, Bath & Body Works presently has an average rating of “Moderate Buy” and a consensus price target of $42.35.

Bath & Body Works Trading Up 0.7 %

Shares of BBWI opened at $31.43 on Monday. The company has a market cap of $6.89 billion, a price-to-earnings ratio of 7.61, a PEG ratio of 0.94 and a beta of 1.77. The company’s fifty day simple moving average is $30.88 and its 200 day simple moving average is $39.05. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. As a group, research analysts forecast that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $0.80 annualized dividend and a yield of 2.55%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.37%.

Insider Transactions at Bath & Body Works

In other news, CEO Gina Boswell purchased 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was acquired at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.